세계의 산업용 산소 발생기 시장 : 가스 유형 및 유량별, 사이즈별, 디자인별, 기술별, 최종 이용 산업별, 지역별 - 예측(-2030년)

The industrial oxygen generator market is estimated to grow from USD 8.36 billion in 2025 to USD 12.47 billion in 2030, at a CAGR of 8.3%. Plug & play oxygen generators hold the second-largest position in the design segment. These oxygen generators are built for rapid deployment, minimal installation complexity, and straightforward operation, ideal for facilities lacking extensive technical infrastructure.

Representing a lucrative segment for manufacturers, these systems are often container-assembled or skid-mounted for straightforward on-site installation, requiring minimal effort, and this design approach significantly reduces installation time and costs for end-users, making the products highly attractive, particularly for facilities seeking rapid deployment. Improved safety is another advantage, as in-house oxygen generators eliminate the need for handling and storing hazardous oxygen cylinders. Manufacturers in this segment focus on compact, preassembled designs that can be operational within hours of delivery, integrating compressors, automated control panels, and weatherproof, vibration-resistant enclosures to ensure reliability across varied environments.

''In terms of value, membrane-based technology type accounted for the third-largest share of the overall industrial oxygen generator market.''

Membrane-based oxygen generators present a different set of design and performance considerations compared to PSA units. These systems rely on selective permeation through polymeric membranes, and the key manufacturing focus is on material science - developing membrane fibers with stable selectivity and flow performance over years of operation. Companies like Air Liquide have optimized compact membrane modules that deliver steady oxygen streams without moving parts, reducing mechanical wear and maintenance needs. From a production standpoint, the engineering challenge lies in ensuring consistent separation efficiency across varying feed air qualities and environmental conditions. Manufacturers invest in pre-filtration and conditioning subsystems to protect membrane integrity, while designing compact, lightweight housings that appeal to mobile or space-constrained installations.

"During the forecast period, the aquaculture end-use industry is projected to witness the third-largest share."

In aquaculture, oxygen generators are critical for maintaining optimal dissolved oxygen levels, which directly impact fish health, growth rates, and production efficiency. Modern systems are designed to deliver a stable oxygen supply under varying environmental conditions, supporting both land-based and offshore farming operations. Atlas Copco's OGV+ VPSA oxygen generators are widely deployed in aquaculture facilities, offering robust and energy-efficient oxygen generation for consistent oxygenation of tanks and sea cages. Linde PLC's ADSOSS-O VPSA units serve large-scale fish farming operations, integrating with oxygen distribution networks to ensure uniform aeration and minimal oxygen loss. These systems are designed for ease of integration, low maintenance, and reliable performance, enabling aquaculture operators to reduce reliance on bulk oxygen deliveries and improve long-term cost efficiency while supporting healthier and more productive aquatic ecosystems.

"During the forecast period, the industrial oxygen generator market in the European region is projected to witness the second-largest market share."

Europe is one of the largest markets in the oxygen generator sector due to its advanced healthcare infrastructure, robust industrial base, and strict environmental regulations. The region's substantial demand comes from hospitals, clinics, and long-term care facilities that require reliable, high-purity oxygen for a large aging and chronically ill population, especially given the high prevalence of respiratory diseases like COPD and asthma. Europe's well-established industries, ranging from metal processing to wastewater treatment and pharmaceuticals, drive continuous demand for both medical and industrial oxygen generators. Governments and regulatory bodies in Europe enforce rigorous standards for air quality and emissions, which have encouraged investment in cleaner, on-site oxygen generation technologies across sectors.

This study has been validated through primary interviews with industry experts globally. These primary sources have been divided into the following three categories:

• By Company Type- Tier 1 - 60%, Tier 2 - 20%, and Tier 3 - 20%
• By Designation- C Level - 33%, Director Level - 33%, and Managers - 34%
• By Region- North America - 20%, Europe - 25%, Asia Pacific - 25%, Middle East & Africa - 15%, and Latin America - 15%

The report provides a comprehensive analysis of company profiles:

Prominent companies include Air Liquide (France), Air Products and Chemicals, Inc. (US), Atlas Copco (Sweden), Linde plc (UK), OXYMAT (Denmark), CAIRE Inc. (US), INMATEC GaseTechnologie GmbH & Co. KG (Germany), Oxygen Generating Systems International (US), PCI Gases (US), GENERON (US), and SYSADVANCE (Portugal).

Research Coverage

This research report categorizes the industrial oxygen generator market by gas type and flow rate (Industrial oxygen, Medical Oxygen), Size (Stationary, Portable), Design (Cylinder, Plug & Play), Technology (Pressure Swing Adsorption (PSA) Based Generator, Membrane-Based Generator, Cryogenic-Based Industrial Generator), End-Use Industry Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America). The scope of the report includes detailed information about the major factors influencing the growth of the industrial oxygen generator market, such as drivers, restraints, challenges, and opportunities. A thorough examination of the key industry players has been conducted in order to provide insights into their business overview, solutions, and services, key strategies, contracts, partnerships, and agreements. Product launches, mergers and acquisitions, and recent developments in the industrial oxygen generator market are all covered. This report includes a competitive analysis of upcoming startups in the industrial oxygen generator market ecosystem.

Reasons to buy this report:

The report will help market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall industrial oxygen generator market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

• Analysis of key drivers (Healthcare infrastructure development boosting hospital and clinic installations of oxygen generators, Chronic respiratory disease cases accelerate oxygen generator adoption, Reducing energy footprints in industrial and medical oxygen supply, stell capacity expansion demands smarter oxygen supply ), restraints (stringent compliance standards pose barriers to oxygen generator market), opportunities (rising aquaculture demand positions oxygen generators for market growth, expanding, ozone applications with high-purity oxygen technology) and challenges (installation and integration costs slowing market expansion, specialized maintenance needs create barriers in oxygen generator operations).
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and service launches in the industrial oxygen generator market
• Market Development: Comprehensive information about lucrative markets - the report analyses the industrial oxygen generator market across varied regions
• Market Diversification: Exhaustive information about services, untapped geographies, recent developments, and investments in the industrial oxygen generator market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as (France), Air Products and Chemicals, Inc. (US), Atlas Copco (Sweden), Linde plc (UK), OXYMAT (Denmark), CAIRE Inc. (US), INMATEC GaseTechnologie GmbH & Co. KG (Germany), Oxygen Generating Systems International (US), PCI Gases (US), GENERON (US), and SYSADVANCE (Portugal) among others in the industrial oxygen generator market

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
  • 1.3.5 UNIT CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 List of key secondary sources
    • 2.1.1.2 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 List of primary interview participants-demand and supply sides
    • 2.1.2.3 Key industry insights
    • 2.1.2.4 Breakdown of interviews with experts
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 FORECAST NUMBER CALCULATION
• 2.4 DATA TRIANGULATION
• 2.5 FACTOR ANALYSIS
• 2.6 RESEARCH ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN INDUSTRIAL OXYGEN GENERATOR MARKET
• 4.2 INDUSTRIAL OXYGEN GENERATOR MARKET, BY GAS TYPE AND FLOW RATE
• 4.3 INDUSTRIAL OXYGEN GENERATOR MARKET, BY SIZE
• 4.4 INDUSTRIAL OXYGEN GENERATOR MARKET, BY DESIGN
• 4.5 INDUSTRIAL OXYGEN GENERATOR MARKET, BY TECHNOLOGY
• 4.6 INDUSTRIAL OXYGEN GENERATOR MARKET, BY END-USE INDUSTRY
• 4.7 INDUSTRIAL OXYGEN GENERATOR MARKET, BY COUNTRY

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising development of healthcare infrastructure
    • 5.2.1.2 Increasing prevalence of chronic respiratory diseases
    • 5.2.1.3 Sustainable oxygen supply through reduced energy use
    • 5.2.1.4 Expanding steel production capacity
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Stringent compliance standards
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Increasing demand in aquaculture industry
    • 5.2.3.2 Rising demand for high-purity oxygen in ozone generation
    • 5.2.3.3 Modernization of power infrastructure
  • 5.2.4 CHALLENGES
    • 5.2.4.1 High installation and integration costs
    • 5.2.4.2 Specialized maintenance needs
• 5.3 PORTER'S FIVE FORCES ANALYSIS
  • 5.3.1 BARGAINING POWER OF SUPPLIERS
  • 5.3.2 BARGAINING POWER OF BUYERS
  • 5.3.3 THREAT OF NEW ENTRANTS
  • 5.3.4 THREAT OF SUBSTITUTES
  • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.4.2 BUYING CRITERIA
• 5.5 MACROECONOMIC INDICATORS
  • 5.5.1 GLOBAL GDP TRENDS
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 CASE STUDY ANALYSIS
  • 5.8.1 ATLAS COPCO OXYGEN GENERATOR ENHANCES BIOGAS STABILITY AT LEEMING FACILITY
  • 5.8.2 SEMP OPTIMIZES WASTEWATER TREATMENT WITH NOVAIR ON-SITE OXYGEN GENERATION
  • 5.8.3 ATLAS COPCO OGP2 SECURES RELIABLE OXYGEN SUPPLY FOR UK VETERINARY CENTRE
• 5.9 REGULATORY LANDSCAPE
  • 5.9.1 REGULATIONS
    • 5.9.1.1 Europe
    • 5.9.1.2 Asia Pacific
    • 5.9.1.3 North America
  • 5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.10 TECHNOLOGY ANALYSIS
  • 5.10.1 KEY TECHNOLOGIES
    • 5.10.1.1 Pressure swing adsorption (PSA)
    • 5.10.1.2 Membrane separation
    • 5.10.1.3 Cryogenic oxygen generation
  • 5.10.2 COMPLEMENTARY TECHNOLOGIES
    • 5.10.2.1 IoT and smart monitoring systems
    • 5.10.2.2 Energy recovery systems
• 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.12 TRADE ANALYSIS
  • 5.12.1 EXPORT SCENARIO (HS CODE 840510)
  • 5.12.2 IMPORT SCENARIO (HS CODE 840510)
• 5.13 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.14 PRICING ANALYSIS
  • 5.14.1 AVERAGE SELLING PRICE TREND, BY REGION, 2022-2024
  • 5.14.2 AVERAGE SELLING PRICE TREND, BY END-USE INDUSTRY, 2022-2030
  • 5.14.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END-USE INDUSTRY, 2024
• 5.15 INVESTMENT AND FUNDING SCENARIO
• 5.16 PATENT ANALYSIS
  • 5.16.1 APPROACH
  • 5.16.2 DOCUMENT TYPES
  • 5.16.3 PUBLICATION TRENDS
  • 5.16.4 INSIGHTS
  • 5.16.5 LEGAL STATUS OF PATENTS
  • 5.16.6 JURISDICTION ANALYSIS
  • 5.16.7 TOP COMPANIES/APPLICANTS
  • 5.16.8 TOP 10 PATENT OWNERS (US)
• 5.17 IMPACT OF 2025 US TARIFF ON INDUSTRIAL OXYGEN GENERATOR MARKET
  • 5.17.1 INTRODUCTION
  • 5.17.2 KEY TARIFF RATES
  • 5.17.3 PRICE IMPACT ANALYSIS
  • 5.17.4 IMPACT ON KEY COUNTRIES/REGIONS
    • 5.17.4.1 North America
    • 5.17.4.2 Europe
    • 5.17.4.3 Asia Pacific
  • 5.17.5 IMPACT ON END-USE INDUSTRIES

6 INDUSTRIAL OXYGEN GENERATOR MARKET, BY GAS TYPE AND FLOW RATE

• 6.1 INTRODUCTION
• 6.2 INDUSTRIAL
  • 6.2.1 FOCUS ON ENHANCING OXYGEN SUPPLY EFFICIENCY ACROSS INDUSTRIAL FLOW RATES TO BOOST DEMAND
  • 6.2.2 UP TO 50 NM3/HR
  • 6.2.3 50-200 NM3/HR
  • 6.2.4 200-1,000 NM3/HR
  • 6.2.5 ABOVE 1,000 NM3/HR
• 6.3 MEDICAL
  • 6.3.1 NEED TO ENSURE CONSISTENT AND SAFE OXYGEN SUPPLY ACROSS MEDICAL FACILITIES TO FUEL DEMAND
  • 6.3.2 UP TO 2 NM3/HR
  • 6.3.3 2.1-14 NM3/HR
  • 6.3.4 15-50 NM3/HR
  • 6.3.5 ABOVE 50 NM3/HR

7 INDUSTRIAL OXYGEN GENERATOR MARKET, BY SIZE

• 7.1 INTRODUCTION
• 7.2 STATIONARY
  • 7.2.1 HIGH-PURITY AND CONTINUOUS OXYGEN SUPPLY FEATURES TO DRIVE DEMAND
• 7.3 PORTABLE 93 7.3.1 RISING USE OF PORTABLE OXYGEN GENERATORS FOR DECENTRALIZED AND REMOTE APPLICATIONS TO DRIVE MARKET

8 INDUSTRIAL OXYGEN GENERATOR MARKET, BY DESIGN

• 8.1 INTRODUCTION
• 8.2 CYLINDER
  • 8.2.1 INCREASING INDUSTRIAL APPLICATIONS TO DRIVE MARKET
• 8.3 PLUG & PLAY
  • 8.3.1 GROWING USE IN MEDICAL AND INDUSTRIAL APPLICATIONS TO PROPEL MARKET

9 INDUSTRIAL OXYGEN GENERATOR MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
• 9.2 PRESSURE SWING ADSORPTION (PSA)-BASED
  • 9.2.1 HIGH EFFICIENCY, OPERATIONAL RELIABILITY, AND ABILITY TO CONSISTENTLY PROVIDE OXYGEN AT DESIRED PURITY LEVEL TO FUEL DEMAND
• 9.3 MEMBRANE-BASED
  • 9.3.1 HIGH POWER EFFICIENCY IN MEMBRANE OXYGEN GENERATION TO PROPEL DEMAND
• 9.4 CRYOGENIC-BASED
  • 9.4.1 GROWING USE OF CRYOGENIC SOLUTIONS IN ENERGY & POWER INDUSTRY TO DRIVE MARKET

10 INDUSTRIAL OXYGEN GENERATOR MARKET, BY END-USE INDUSTRY

• 10.1 INTRODUCTION
• 10.2 MEDICAL & HEALTHCARE
  • 10.2.1 RISING OXYGEN GENERATION FOR EMERGENCY, INSTITUTIONAL, AND HOME CARE NEEDS TO DRIVE MARKET
• 10.3 CHEMICALS & PETROCHEMICALS
  • 10.3.1 NEED TO MEET HIGH-PURITY, HIGH-VOLUME OXYGEN DEMAND IN HARSH INDUSTRIAL ENVIRONMENTS TO PROPEL MARKET
• 10.4 MINING & METAL PROCESSING
  • 10.4.1 RISING NEED FOR OXYGEN IN MINERAL PROCESSING AND SMELTING TO DRIVE DEMAND
• 10.5 POWER GENERATION
  • 10.5.1 SHIFT TOWARD OXYGEN-ENRICHED COMBUSTION FOR HIGHER EFFICIENCY AND LOWER EMISSIONS TO PROPEL DEMAND
• 10.6 AQUACULTURE
  • 10.6.1 USE TO MAINTAIN OPTIMAL DISSOLVED OXYGEN LEVELS TO FUEL MARKET GROWTH
• 10.7 WATER TREATMENT
  • 10.7.1 RISING DEMAND IN HIGH-PURITY PROCESSES TO DRIVE MARKET
• 10.8 OTHER END-USE INDUSTRIES

11 INDUSTRIAL OXYGEN GENERATOR MARKET, BY REGION

• 11.1 INTRODUCTION
• 11.2 NORTH AMERICA
  • 11.2.1 US
    • 11.2.1.1 Rising demand from aquaculture and power generation industries to drive market
  • 11.2.2 CANADA
    • 11.2.2.1 Infrastructure upgrades and expanding healthcare sector to boost market growth
  • 11.2.3 MEXICO
    • 11.2.3.1 Increasing adoption in energy and aquaculture industries to drive market
• 11.3 EUROPE
  • 11.3.1 GERMANY
    • 11.3.1.1 Rising demand from aquaculture industry to drive market
  • 11.3.2 FRANCE
    • 11.3.2.1 Enhancement of efficiency in power generation using oxygen technologies to drive demand
  • 11.3.3 UK
    • 11.3.3.1 Booming healthcare sector to fuel demand
  • 11.3.4 ITALY
    • 11.3.4.1 Expanding on-site oxygen generator market to fuel demand
  • 11.3.5 SPAIN
    • 11.3.5.1 Growing industrial sector to fuel demand
  • 11.3.6 REST OF EUROPE
• 11.4 ASIA PACIFIC
  • 11.4.1 CHINA
    • 11.4.1.1 Expanding healthcare industry to fuel demand
  • 11.4.2 JAPAN
    • 11.4.2.1 Increasing industrial demand to drive market
  • 11.4.3 INDIA
    • 11.4.3.1 Growing medical & healthcare industries to propel market
  • 11.4.4 SOUTH KOREA
    • 11.4.4.1 Stringent government policies regarding medical equipment to drive market
  • 11.4.5 AUSTRALIA
    • 11.4.5.1 Growing use in mining & metals industry to boost market
  • 11.4.6 REST OF ASIA PACIFIC
• 11.5 SOUTH AMERICA
  • 11.5.1 BRAZIL
    • 11.5.1.1 Increasing demand across healthcare, metal, chemical, aquaculture, and water treatment industries to drive market
  • 11.5.2 ARGENTINA
    • 11.5.2.1 Modernization of industrial sector to drive market
  • 11.5.3 COLUMBIA
    • 11.5.3.1 Booming industrial sector to fuel demand
  • 11.5.4 CHILE
    • 11.5.4.1 Increased demand in aquaculture industry to drive market
  • 11.5.5 REST OF SOUTH AMERICA
• 11.6 MIDDLE EAST & AFRICA
  • 11.6.1 GCC COUNTRIES
    • 11.6.1.1 Saudi Arabia
      • 11.6.1.1.1 Vision 2030 and NEOM megaproject to support market growth
    • 11.6.1.2 UAE
      • 11.6.1.2.1 Government-led initiatives for industrial diversification, healthcare expansion, and sustainability to drive market
    • 11.6.1.3 Rest of GCC countries
  • 11.6.2 SOUTH AFRICA
    • 11.6.2.1 Enhancement of sustainability through on-site oxygen generation to fuel demand
  • 11.6.3 REST OF MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

• 12.1 OVERVIEW
• 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 12.3 REVENUE ANALYSIS
• 12.4 MARKET SHARE ANALYSIS
• 12.5 COMPANY VALUATION AND FINANCIAL METRICS
• 12.6 BRAND/PRODUCT COMPARISON ANALYSIS
• 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 12.7.1 STARS
  • 12.7.2 EMERGING LEADERS
  • 12.7.3 PERVASIVE PLAYERS
  • 12.7.4 PARTICIPANTS
  • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 12.7.5.1 Company footprint
    • 12.7.5.2 Region footprint
    • 12.7.5.3 Gas type and flow rate footprint
    • 12.7.5.4 Size footprint
    • 12.7.5.5 Design footprint
    • 12.7.5.6 Technology footprint
    • 12.7.5.7 End-use industry footprint
• 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 12.8.1 PROGRESSIVE COMPANIES
  • 12.8.2 RESPONSIVE COMPANIES
  • 12.8.3 DYNAMIC COMPANIES
  • 12.8.4 STARTING BLOCKS
  • 12.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024
    • 12.8.5.1 Detailed list of key startups/SMEs
    • 12.8.5.2 Competitive benchmarking of key startups/SMEs
• 12.9 COMPETITIVE SCENARIO
  • 12.9.1 PRODUCT LAUNCHES
  • 12.9.2 EXPANSIONS
  • 12.9.3 DEALS

13 COMPANY PROFILES

• 13.1 KEY PLAYERS
  • 13.1.1 AIR LIQUIDE
    • 13.1.1.1 Business overview
    • 13.1.1.2 Products/Solutions/Services offered
    • 13.1.1.3 Recent developments
      • 13.1.1.3.1 Expansions
    • 13.1.1.4 MnM view
      • 13.1.1.4.1 Key strengths/Right to win
      • 13.1.1.4.2 Strategic choices
      • 13.1.1.4.3 Weaknesses/Competitive threats
  • 13.1.2 AIR PRODUCTS AND CHEMICALS, INC.
    • 13.1.2.1 Business overview
    • 13.1.2.2 Products/Solutions/Services offered
    • 13.1.2.3 Recent developments
      • 13.1.2.3.1 Deals
    • 13.1.2.4 MnM view
      • 13.1.2.4.1 Key strengths/Right to win
      • 13.1.2.4.2 Strategic choices
      • 13.1.2.4.3 Weaknesses/Competitive threats
  • 13.1.3 ATLAS COPCO GROUP
    • 13.1.3.1 Business overview
    • 13.1.3.2 Products/Solutions/Services offered
    • 13.1.3.3 Recent developments
      • 13.1.3.3.1 Deals
    • 13.1.3.4 MnM view
      • 13.1.3.4.1 Key strengths/Right to win
      • 13.1.3.4.2 Strategic choices
      • 13.1.3.4.3 Weaknesses/Competitive threats
  • 13.1.4 LINDE PLC
    • 13.1.4.1 Business overview
    • 13.1.4.2 Products/Solutions/Services offered
    • 13.1.4.3 Recent developments
      • 13.1.4.3.1 Deals
    • 13.1.4.4 Recent developments
      • 13.1.4.4.1 Expansions
    • 13.1.4.5 MnM view
      • 13.1.4.5.1 Key strengths/Right to win
      • 13.1.4.5.2 Strategic choices
      • 13.1.4.5.3 Weaknesses/Competitive threats
  • 13.1.5 OXYMAT
    • 13.1.5.1 Business overview
    • 13.1.5.2 Products/Solutions/Services offered
    • 13.1.5.3 Recent developments
      • 13.1.5.3.1 Deals
    • 13.1.5.4 MnM view
      • 13.1.5.4.1 Key strengths/Right to win
      • 13.1.5.4.2 Strategic choices
      • 13.1.5.4.3 Weaknesses/Competitive threats
  • 13.1.6 CAIRE INC.
    • 13.1.6.1 Business overview
    • 13.1.6.2 Products/Solutions/Services offered
    • 13.1.6.3 Recent developments
      • 13.1.6.3.1 Product launches
      • 13.1.6.3.2 Expansions
    • 13.1.6.4 MnM view
  • 13.1.7 INMATEC GASETECHNOLOGIE GMBH & CO. KG
    • 13.1.7.1 Business overview
    • 13.1.7.2 Products/Solutions/Services offered
    • 13.1.7.3 MnM view
  • 13.1.8 OXYGEN GENERATING SYSTEMS
    • 13.1.8.1 Business overview
    • 13.1.8.2 Products/Solutions/Services offered
    • 13.1.8.3 MnM view
  • 13.1.9 PCI GASES
    • 13.1.9.1 Business overview
    • 13.1.9.2 Products/Solutions/Services offered
    • 13.1.9.3 MnM view
  • 13.1.10 GENERON
    • 13.1.10.1 Business overview
    • 13.1.10.2 Products/Solutions/Services offered
    • 13.1.10.3 MnM view
  • 13.1.11 SYSADVANCE
    • 13.1.11.1 Business overview
    • 13.1.11.2 Products/Solutions/Services offered
    • 13.1.11.3 MnM view
  • 13.1.12 SUMER A.S.
    • 13.1.12.1 Business overview
    • 13.1.12.2 Products/Solutions/Services offered
    • 13.1.12.3 MnM view
  • 13.1.13 OXYVITAL
    • 13.1.13.1 Business overview
    • 13.1.13.2 Products/Solutions/Services offered
    • 13.1.13.3 MnM view
  • 13.1.14 ORECO A/S
    • 13.1.14.1 Business overview
    • 13.1.14.2 Products/Solutions/Services offered
    • 13.1.14.3 MnM view
  • 13.1.15 FRITZ STEPHAN GMBH
    • 13.1.15.1 Business overview
    • 13.1.15.2 Products/Solutions/Services offered
    • 13.1.15.3 MnM view
  • 13.1.16 OZCAN KARDESLER
    • 13.1.16.1 Business overview
    • 13.1.16.2 Products/Solutions/Services offered
    • 13.1.16.3 MnM view
  • 13.1.17 BEACONMEDAES
    • 13.1.17.1 Business overview
    • 13.1.17.2 Products/Solutions/Services offered
    • 13.1.17.3 MnM view
  • 13.1.18 GAZ SYSTEMES
    • 13.1.18.1 Business overview
    • 13.1.18.2 Products/Solutions/Services offered
    • 13.1.18.3 MnM view
  • 13.1.19 MIL'S
    • 13.1.19.1 Business overview
    • 13.1.19.2 Products/Solutions/Services offered
    • 13.1.19.3 MnM view
• 13.2 OTHER PLAYERS
  • 13.2.1 NOXERIOR
  • 13.2.2 ADVANCED GAS TECHNOLOGIES INC.
  • 13.2.3 PNEUMATECH
  • 13.2.4 AMCAREMED MEDICAL GAS SYSTEM
  • 13.2.5 SUMITOMO SEIKA CHEMICALS CO., LTD.
  • 13.2.6 INGERSOLL RAND

14 APPENDIX

• 14.1 DISCUSSION GUIDE
• 14.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 14.3 CUSTOMIZATION OPTIONS
• 14.4 RELATED REPORTS
• 14.5 AUTHOR DETAILS